tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
GNI Group’s Gyre Therapeutics Begins Phase 1 Trial for PAH Drug in China
PremiumCompany AnnouncementsGNI Group’s Gyre Therapeutics Begins Phase 1 Trial for PAH Drug in China
3M ago
GNI Group’s Gyre Pharmaceuticals Launches Etorel for Pulmonary Fibrosis
Premium
Company Announcements
GNI Group’s Gyre Pharmaceuticals Launches Etorel for Pulmonary Fibrosis
3M ago
GNI Group’s Subsidiary Gyre Therapeutics Completes Successful Public Offering
Premium
Company Announcements
GNI Group’s Subsidiary Gyre Therapeutics Completes Successful Public Offering
3M ago
GNI Group Issues Stock Options Tied to Drug Approval Milestone
PremiumCompany AnnouncementsGNI Group Issues Stock Options Tied to Drug Approval Milestone
4M ago
GNI Group Projects Record Sales and Profits Amid U.S.-China Tariff Concerns
Premium
Company Announcements
GNI Group Projects Record Sales and Profits Amid U.S.-China Tariff Concerns
5M ago
GNI Group Amends FY2024 Financial Results Following Tax Review
Premium
Company Announcements
GNI Group Amends FY2024 Financial Results Following Tax Review
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100